This inventor holds 1 USPTO granted patent. Top assignee: Ursapharm Arzneimittel Gmbh. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Holger Seelert: Inventor in Pharmaceutical Research
Introduction
Holger Seelert is an inventor associated with Pirmasens, Germany, and Ursapharm Arzneimittel GmbH. His patent work concerns bromelain-related proteins and their potential use in addressing coronavirus infections.
Latest Patents
Seelert is listed as an inventor on 1 patent. The patent describes bromelain protease, bromelain, jacalin-like lectin, pineapple plant extracts, combination preparations, bromelain protease inhibitors, protein/protease mixtures, and glycated bromelain protein for use in the treatment or prophylaxis of coronavirus infections in humans or animals.
Career Highlights
The available information connects Seelert’s patent activity with Ursapharm Arzneimittel GmbH and pharmaceutical research into potential applications of pineapple-derived compounds and related proteins.
Collaborations
Peter Gross and Rolf Müller are identified as Seelert’s coworkers. The patent information provided does not specify their individual roles or confirm their participation in the listed patent.
Conclusion
Holger Seelert’s recorded invention focuses on bromelain-related compounds and their proposed use against coronavirus infections, reflecting a pharmaceutical research effort associated with Ursapharm Arzneimittel GmbH.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile